Markers Predicting Response to Bacillus Calmette-Guérin Immunotherapy in High-Risk Bladder Cancer Patients: A Systematic ReviewTahlita C.M. Zuiverloon, Ellen C. Zwarthoff, Annemieke J.M. Nieuweboer et al.|European Urology|2011Cited by 175
Genome-wide Analysis of CpG Island Methylation in Bladder Cancer Identified TBX2, TBX3, GATA2, and ZIC4 as pTa-Specific Prognostic MarkersRaju Kandimalla, Ellen C. Zwarthoff, Angela A.G. van Tilborg et al.|European Urology|2012Cited by 106
The <i>FGFR3</i> Mutation is Related to Favorable pT1 Bladder CancerBas W.G. van Rhijn, Bharati Bapat, Theodorus van der Kwast et al.|The Journal of Urology|2011Cited by 102
<i>Fibroblast Growth Factor Receptor 3</i> Mutation Analysis on Voided Urine for Surveillance of Patients with Low-Grade Non-Muscle–Invasive Bladder CancerTahlita C.M. Zuiverloon, Ellen C. Zwarthoff, Ewout W. Steyerberg et al.|Clinical Cancer Research|2010Cited by 102
Prognostic value of molecular markers, sub‐stage and European Organisation for the Research and Treatment of Cancer risk scores in primary T1 bladder cancerBas W.G. van Rhijn, Alexandre R. Zlotta, Liyang Liu et al.|British Journal of Urology|2012Cited by 64